Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Learn how to weight dividend ETFs by income versus growth to tailor risk, cash flow, and long-term growth in your retirement portfolio.
23,884 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This article breaks down Quaker Chemical's Q4 2025 earnings implications, real-world drivers, and practical steps you...
Tesla is signaling a bold move beyond traditional EVs. This article examines tesla stock's bold strategic shift, what...
SentinelOne hit a $1 billion ARR milestone as revenue growth decelerated and operating margins improved, but investor...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
Could Tesla ride a $10 trillion wave of opportunity before 2029? This analysis breaks down the bets, the risks, and p...
Celina, Texas leads the nation in growth for a second year, marking a trend toward Texas suburbs where the american d...
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...
Dream Finders Homes has named Rick Beckwitt, the long‑time Lennar executive, as co-chair of its board, a move aimed a...